Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Leukemia, Biphenotypic, Acute 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Osteosarcoma 4Leukemia 4Neoplasm Metastasis 3Myelodysplastic Syndromes 3Down Syndrome 3Rhabdoid Tumor 2Recurrence 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Head and Neck Neoplasms 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Blast Crisis 2Urothelial Carcinoma of the Bladder 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Oropharyngeal Neoplasms 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Multiple Myeloma 1

Interventions

pembrolizumab 38Bevacizumab 23Cyclophosphamide 22Standard of Care 18Blood Specimen Collection 17Carboplatin 16Paclitaxel 15Nivolumab 14Gemcitabine 14Pemetrexed 13Exercise 13Cisplatin 12atezolizumab 11Radiotherapy 11Fluorouracil 11Doxorubicin 11Surveys and Questionnaires 9Rituximab 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Cetuximab 9Biopsy 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Docetaxel 8olaparib 7Temozolomide 7Prednisone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Methotrexate × 90 days × Clear all
NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡